Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.

GSK and other drugmakers have lost no time in filing an appeal to a Delaware court’s decision to allow more than 70,000 Zantac-related lawsuits to go ahead. Just over a week ago, Judge Vivian ...

His oral medications prior to admission included topiramate 100 mg twice daily, ranitidine hydrochloride 75 mg twice daily, ferrous sulfate 325 mg twice daily, potassium chloride 10 meq once daily ...

A comprehensive literature review was conducted for all medications on the formulary of Bedlam Clinic, a free evening clinic for the medically indigent or working poor, offered by the University ...

AMP price predictions hint at a maximum price of $0.0044 by the end of 2024 while maintaining an average price of $0.0042. In 2027, the price of AMP will range between $0.0126 and $0.0151, with an ...

Read more about Cryptonews AMP is the collateral token for the Flexa payments network and the governance token for the Ampera Foundation. It plays a critical role in facilitating crypto payments to ...

Provides financial advice and superannuation, retirement income, banking and investment products across a portfolio of businesses along with corporate superannuation products and services for ...

Missing DC Bias Current Return Path When AC-Coupled One of the most common application problems encountered is the failure to provide a dc return path for bias current in ac-coupled operational- or ...